Literature DB >> 29052614

Narp Mediates Antidepressant-Like Effects of Electroconvulsive Seizures.

Andrew D Chang1, Punit V Vaidya1, Edward P Retzbach1, Sunho J Chung1, Urian Kim1, Kathryn Baselice1, Kristen Maynard2, Alec Stepanian1, Melissa Staley1, Lan Xiao1, Ashley Blouin1, Sungho Han1, JongAh Lee1, Paul F Worley1, Kellie L Tamashiro1, Barbara L Hempstead3, Keri Martinowich1,2, Mary Ann Wilson1,4, Jay M Baraban1, Irving M Reti1.   

Abstract

Growing recognition of persistent cognitive defects associated with electroconvulsive therapy (ECT), a highly effective and commonly used antidepressant treatment, has spurred interest in identifying its mechanism of action to guide development of safer treatment options. However, as repeated seizure activity elicits a bewildering array of electrophysiological and biochemical effects, this goal has remained elusive. We have examined whether deletion of Narp, an immediate early gene induced by electroconvulsive seizures (ECS), blocks its antidepressant efficacy. Based on multiple measures, we infer that Narp knockout mice undergo normal seizure activity in this paradigm, yet fail to display antidepressant-like behavioral effects of ECS. Although Narp deletion does not suppress ECS-induced proliferation in the dentate gyrus, it blocks dendritic outgrowth of immature granule cell neurons in the dentate molecular layer induced by ECS. Taken together, these findings indicate that Narp contributes to the antidepressant action of ECT and implicate the ability of ECS to induce dendritic arborization of differentiating granule cells as a relevant step in eliciting this response.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29052614      PMCID: PMC5854807          DOI: 10.1038/npp.2017.252

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  59 in total

Review 1.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

2.  Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF.

Authors:  Tomoya Matsumoto; Stefanie Rauskolb; Martin Polack; Johannes Klose; Roland Kolbeck; Martin Korte; Yves-Alain Barde
Journal:  Nat Neurosci       Date:  2008-01-20       Impact factor: 24.884

3.  Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp.

Authors:  R J O'Brien; D Xu; R S Petralia; O Steward; R L Huganir; P Worley
Journal:  Neuron       Date:  1999-06       Impact factor: 17.173

Review 4.  Feeling strained? Influence of genetic background on depression-related behavior in mice: a review.

Authors:  L H Jacobson; J F Cryan
Journal:  Behav Genet       Date:  2006-09-23       Impact factor: 2.805

Review 5.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

6.  Prominent Narp expression in projection pathways and terminal fields.

Authors:  Irving M Reti; Radhika Reddy; Paul F Worley; Jay M Baraban
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

7.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

8.  Narp regulates long-term aversive effects of morphine withdrawal.

Authors:  Irving M Reti; Hans S Crombag; Kogo Takamiya; Jeffrey M Sutton; Ning Guo; Megan L Dinenna; Richard L Huganir; Peter C Holland; Jay M Baraban
Journal:  Behav Neurosci       Date:  2008-08       Impact factor: 1.912

9.  Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy.

Authors:  R H Segman; B Shapira; M Gorfine; B Lerer
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

Review 10.  Functional circuits of new neurons in the dentate gyrus.

Authors:  Carmen Vivar; Henriette van Praag
Journal:  Front Neural Circuits       Date:  2013-02-25       Impact factor: 3.492

View more
  4 in total

1.  Induction of Bdnf from promoter I following electroconvulsive seizures contributes to structural plasticity in neurons of the piriform cortex.

Authors:  Anthony D Ramnauth; Kristen R Maynard; Alisha S Kardian; BaDoi N Phan; Madhavi Tippani; Sumita Rajpurohit; John W Hobbs; Stephanie Cerceo Page; Andrew E Jaffe; Keri Martinowich
Journal:  Brain Stimul       Date:  2022-02-17       Impact factor: 8.955

2.  Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia.

Authors:  Diğdem Göverti; Nihan Büyüklüoğlu; Hasan Kaya; Rabia Nazik Yüksel; Çiğdem Yücel; Erol Göka
Journal:  Psychopharmacology (Berl)       Date:  2022-04-28       Impact factor: 4.415

3.  The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies.

Authors:  Juliette Giacobbe; Carmine M Pariante; Alessandra Borsini
Journal:  J Psychopharmacol       Date:  2020-07-10       Impact factor: 4.153

4.  Electroconvulsive stimulation attenuates chronic neuroinflammation.

Authors:  Smadar Goldfarb; Nina Fainstein; Tamir Ben-Hur
Journal:  JCI Insight       Date:  2020-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.